Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes

<div>The miRNAs expressed levels from qRT-PCR data between the nonfibrosis group and fibrosis group. The levels of miR-144-5p (a), miR-18a-5p (b), miR-148b-3p (c), miR-654-3p (d), miR-139-3p (e), and miR-24-1-5p (f) in CHB patients with liver fibrosis (<i>n</i> = 15) and nonfibrosis (<i>n</i> = 12) were measured by qRT-PCR. The line at each group represents the median value of indicated miRNA.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes 

Figure 2 | Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine Syndromes 